share_log

Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024

默沙東 | 8-K: Peter C. Wendell通知默沙東打算在2024年5月28日公司2024年年度股東大會上退出公司董事會

美股SEC公告 ·  02/20 16:20

Moomoo AI 已提取核心訊息

On February 15, 2024, Peter C. Wendell notified Merck & Co., Inc. of his decision to retire from the company's Board of Directors effective May 28, 2024, coinciding with Merck's Annual Meeting of Shareholders. The announcement, made through a Form 8-K filing with the SEC, clarified that Wendell's retirement is not due to any disagreements regarding the company's operations, policies, or practices. Merck & Co., headquartered in Rahway, New Jersey, confirmed the report on February 20, 2024, and reassured that the company's securities, including common stock and various notes, remain registered with the New York Stock Exchange.
On February 15, 2024, Peter C. Wendell notified Merck & Co., Inc. of his decision to retire from the company's Board of Directors effective May 28, 2024, coinciding with Merck's Annual Meeting of Shareholders. The announcement, made through a Form 8-K filing with the SEC, clarified that Wendell's retirement is not due to any disagreements regarding the company's operations, policies, or practices. Merck & Co., headquartered in Rahway, New Jersey, confirmed the report on February 20, 2024, and reassured that the company's securities, including common stock and various notes, remain registered with the New York Stock Exchange.
2024 年 2 月 15 日,彼得·溫德爾通知默沙東公司,他決定從公司董事會退休,從 2024 年 5 月 28 日起生效,這恰逢默沙東的年度股東大會。該公告是通過向美國證券交易委員會提交的8-K表格發佈的,澄清說,溫德爾的退休不是由於公司的運營、政策或做法存在任何分歧造成的。總部位於新澤西州拉威的默沙東公司於2024年2月20日證實了該報告,並保證該公司的證券,包括普通股和各種票據,仍在紐約證券交易所註冊。
2024 年 2 月 15 日,彼得·溫德爾通知默沙東公司,他決定從公司董事會退休,從 2024 年 5 月 28 日起生效,這恰逢默沙東的年度股東大會。該公告是通過向美國證券交易委員會提交的8-K表格發佈的,澄清說,溫德爾的退休不是由於公司的運營、政策或做法存在任何分歧造成的。總部位於新澤西州拉威的默沙東公司於2024年2月20日證實了該報告,並保證該公司的證券,包括普通股和各種票據,仍在紐約證券交易所註冊。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息